Tofacitinib 5mg Tablets$78.00
1–9 boxes
$78.00 each
10–24 boxes
8% off
25+ boxes
10% off
Tofacitinib 5mg Tablets
SKU GME644Product Introduction
Tofacitinib is a Janus kinase inhibitor used for selected inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or ulcerative colitis under the relevant indication. Dose and eligibility vary by condition.
How to use
Take the prescribed immediate-release schedule with or without food. A 5mg tablet schedule must not be assumed to be equivalent to an extended-release product or an ulcerative-colitis induction regimen.
How it works
JAK inhibition reduces intracellular signalling from inflammatory cytokines, modifying immune activity.
Side effects
Respiratory infections, headache, diarrhoea, shingles and lipid or blood-count changes can occur.
Important information
Screening for tuberculosis and viral hepatitis, blood counts, liver tests and lipids are needed. Serious infection, malignancy, cardiovascular events and thrombosis are important labelled risks.
Uses
- Selected inflammatory arthritis and ulcerative-colitis indications after specialist assessment
Benefits
Can reduce inflammatory disease activity when its benefits outweigh the infection and other systemic risks.
Can I receive live vaccines during treatment?
Live vaccines are generally avoided; review vaccination needs before starting.
Why is tuberculosis screening needed?
Immune suppression can reactivate latent tuberculosis.
What infection symptoms should prompt contact?
Fever, persistent cough, painful rash or other new infection symptoms should be reported promptly.
Is a new painful one-sided leg swelling urgent?
Yes. It can indicate a clot; chest pain or breathlessness requires emergency assessment.
Can it be combined with another biological immune treatment?
Such combinations are generally not recommended without a specific specialist plan.
Does the 5mg strength identify one schedule for every disease?
No. Indication, kidney or liver function and interactions affect the regimen.
Why are cholesterol tests repeated?
Tofacitinib can raise lipids even when inflammatory symptoms improve.
Does improvement mean monitoring can stop?
No. Infection and laboratory risks remain relevant during ongoing treatment.
JAK: Janus kinase, a signalling enzyme. Cytokine: an immune-signalling protein. Herpes zoster: shingles., AR: Tofacitinib أقراص, FR: Tofacitinib comprimés, PT: Tofacitinib comprimidos, ES: Tofacitinib comprimidos, RU: Tofacitinib таблетки, ID: Tofacitinib, VI: Tofacitinib viên nén, MS: Tofacitinib, TL: Tofacitinib tableta, ZH-SG: Tofacitinib 片剂